NEW DELHI, February 27, 2018 /PRNewswire/ --
After receiving over 180 applications from digital health innovatorsaround the world, HITLAB and Unitus Seed Fund, through its StartHealth initiative, are pleased to announce that Medi360, a cloud-based telehealth solution, was the winner of the 2018 HITLAB World Cup competition, part of the HITLAB Innovators Summit
(Logo: http://mma.prnewswire.com/media/456367/PRNE_HITLAB_logo_Logo.jpg )
"It was a great experience participating in the HITLAB World Cup as one of the finalists and we are extremely thrilled to be recognized as the winner. This provides further fuel to our motivation in the journey of making a meaningful impact to healthcare in India," said Kumar Amar Jamdhiar, CEO of Medi360.
Runners-up include MUrgency, a medical resources aggregator, Mother Diagnostics, a low-cost digital X-ray device, Mimyk Medical Simulations, an immersive medical simulation technology, and VOTIS Subdermal Imaging, a non-invasive and inexpensive technology to identify foot pathologies in diabetics. Winners will now be considered for up to USD $500,000 (INR 3.5 crore) in grants and equity funding by Unitus Seed Fund and its AmpHealth program to fund their continued work and expansion.
"Presenting at the HITLAB Innovators Summit is an unparalleled opportunity for innovators to showcase their work before an international audience of leaders in public health, medicine, science, technology, and design," said Stan Kachnowski, HITLAB Chair. "We are excited to see how these digital startups will improve the healthcare system in India. The support that Unitus and HITLAB can provide these impactful organizations as they grow will prove invaluable as they bring innovative, transformational technologies to the people who need them."
The HITLAB World Cup judges - representing senior leadership at Unitus, HITLAB, Boston Scientific, and All India Institute of Medical Sciences (AIIMS) - reviewed applications from a wide range of innovative companies working in artificial intelligence, telehealth, home health, mobile applications, and biotech devices. Entries were judged on their impact, innovation, sustainability, and feasibility.
The Innovators Summit featured speakers from leading organizations including Johnson & Johnson, Stryker, IBM, PATH, Terumo, and more. The theme for this Summit - the fourth in India - was Enabling Inclusive Digital Health Innovation and Diffusion.
For more than 15 years, HITLAB has helped leading organizations ideate, create, evaluate, and diffuse technology-based solutions to pressing healthcare challenges. It has hosted the annual HITLAB World Cup Challenge since 2006. Past innovations have ranged from a tech-enabled dynamic scoliosis brace to a voice-activated blockchain ecosystem for diabetic patients and caregivers. Winners have since raised over $50 million in follow-on investment funding and launched commercially viable products that transform lives.
HITLAB is an innovation and teaching lab dedicated to improving the quality and accessibility of healthcare worldwide. We help leading organizations ideate, create, evaluate, and diffuse technology-based solutions to pressing healthcare challenges.
Our team of public health professionals, statisticians, clinicians, engineers, economists, strategists, designers, and anthropologists is determined to address healthcare needs across the globe. We work with a wide variety of stakeholders in both the public and private sectors to design and disseminate studies, programs, and products that improve healthcare access and delivery.
For more information, please visit http://www.hitlab.org or follow the company on Twitter @HITLabNYC.
About Unitus Seed Fund
Unitus Seed Fund is the leading impact venture fund investing in innovative healthcare, educational, and fintech startups in India. Founded in 2012, Unitus Seed Fund is a part of Capria Network, a unit of Capria Ventures at The Unitus Group. Unitus Seed Fund is based in Bangalore and Seattle.
Visit http://www.usf.vc for more information.
Media Contact : Devmalya Sarkar firstname.lastname@example.org +91-9205058722 Manager - India, HITLAB
Subscribe to our Free Newsletters!
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...
Blount's disease is a developmental disorder in which the shinbone is affected, resulting in ...View All